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the enzyme p160ROCK is one of the downstream mediators in the pathway. LIM kinase is an enzyme that
is activated by p160ROCK. We have hypothesized that LIM kinase acts downstream of p160ROCK in the
signaling pathway. Our results showed that LIM kinase is present and activated during development when
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Characterization of LIM Kinase and Activity in Early Amphibian Embryos
Abstract
EphA4 is a cellular receptor that functions in mediating tissue interactions in embryonic
development. The downstream effectors of EphA4 are mainly unknown, although previous
research has indicated that the enzyme p160ROCK is one of the downstream mediators in the
pathway. LIM kinase is an enzyme that is activated by p160ROCK. We have hypothesized that
LIM kinase acts downstream of p160ROCK in the signaling pathway. Our results showed that
LIM kinase is present and activated during development when EphA4 is active in the embryo,
which is consistent with a role for LIM kinase in EphA4 signaling. Further testing is necessary to
determine if LIM kinase has an active role in EphA4 signaling.
Introduction
LIM kinases are a special member of the LIM family proteins which contain a catalytic
domain. The LIM domain consists of a cysteine-rich sequence and a unique double zinc finger
motif. (Takahashi et al. 2001) The LIM domain mediates precise protein to protein interactions.
LIM kinase (LIMK) is identified by two tandemly arrayed LIM domains at the N-terminus, a
protein kinase at the C-terminus, and a PDZ-like motif at the interposing region. The LIM motif
contains fifty to sixty amino acids and was named for the three homeodomain-containing
regions; Lin-11, Isl-1, and Mec-3 (Okano et al. 1995).
LIMK catalyzes the phosphorylation of an N-terminal serine residue of cofilin, which acts
as a regulator of actin dynamics. Cofilin is a type of actin-severing protein in eukaryotic cells and

acts by removing actin monomers from the ends of F-actin or by severing the actin filaments
(Rosenblatt et al. 1997).
There are two genes for LIMK; LIMK1 and LIMK2. LIMK1 and LIMK2 are expressed in the
adult brain and the developing neural tissues, which suggest a role in neural development and
function (Nunoue et al. 1995). In Xenopus laevis, LIMK1 was found in developing tissue areas
such as the brain, eyes, and branchial arches (Thirone et al. 2008). LIMK1 is also expressed in
oocytes and during the cleavage stages of the embryo, which also suggests an early
developmental role for LIMK1 (Takahashi et al. 1995).
LIMK1 is phosphorylated by Rho kinase (ROCK1) at Thr508, whereas LIMK2 is
phosphorylated by ROCK1 at Thr505. ROCK1 enhances the ability of LIMK to phosphorylate
cofilin. Cdc442 and Rac effecter p21-activated kinases (PAKs) also phosphorylate LIMK1, leading
to cofilin phosphorylation (Maekawa et al. 1999).
ROCK1 is a kinase that is involved in the EphA4 signaling pathway. EphA4 is a member of
the receptor tyrosine kinases (RTKs). Eph RTKs have certain ligands, called ephrins that form
receptor-ligand complexes important in axonal growth, segmentation of the hindbrain and
somites, control of cell migration, neural crest development, and vasculogenesis (Holder and
Klein 1999).
The EphA4 signaling pathway is not completely known, but includes several downstream
effectors including the cytoplasmic tyrosine kinase p59fyn, the small GTPase Rho, and ROCK1.
The EphA4 pathway is responsible for regulating the actin cytoskeleton. EphA4 appears to
inhibit RhoA which causes downstream effects in Xenopus laevis (Winning et al 2002). When

RhoA binds to the Rho-binding domain of ROCK, a conformational change occurs at the
carboxyl terminus. The activation of ROCK leads to actin filament stabilization (Tsai and Wei
2010).
We hypothesize that because EphA4 activation inhibits Rho and thereby ROCK1, LIMK1
and/or LIMK2 are likely inactivated in the EphA4 signaling pathway. The purpose of this project
was to determine if LIMK1 or LIMK2 is expressed during the appropriate stages in development
for it to be involved in the EphA4 signaling pathway. If LIMK is involved, it would need to be
expressed during development when EphA4 is functioning in the embryo.
Materials and Methods
Female Xenopus laevis frogs were injected with 900 units of human chorionic
gonadotropinm to induce ovulation. Twelve hours after the injection the frogs were squeezed
so the frogs would shed the eggs. One testis from a male frog was macerated to liberate the
sperm; the male frogs were sacrificed. The sperm suspension was added to the eggs and the
mixture was gently shaken on a rotating platform for twenty minutes. The eggs were then
dejellied using a solution of 2% cysteine, ph 7.8-8.1. The dejellied eggs were then rinsed several
times in distilled water and transferred to Multiply Modified Ringer’s (MMR).
At various stages, embryos were placed in microcentrifuge tubes and frozen at -70°C.
Subsequently, frozen embryos were homogenized and used to prepare RNA or protein extracts.
For protein samples, embryos were homogenized, then extracted once with an equal volume of
freon (1,1,2 trichloro-trifluoro-ethane) to remove yolk proteins. Following this, ½ volume of
Protein Sample Buffer (New England Biolabs) was added, along with 1/30 volume of

dithiothreitol (DTT). Samples were mixed and heated to 100°C for 5 minutes to denature the
proteins.
RNA was isolated from embryos using an Ambion Ribopure kit. Single-stranded cDNA
from stages 9, 11, and 20 was prepared from heat-denatured RNA using reverse transcriptase.
Table 1 indicates reactants and amounts used for the reaction. The RNA, random decamers,
and nuclease-free water were mixed together and heated at three minutes at 80°C. The tubes
were removed from heat and placed on ice. The remaining RT components were added to the
mixtures. The reaction tubes were then mixed and incubated at 42.1°C for two hours. The
reaction tubes were incubated for ten minutes at 65°C to inactivate the reverse transcriptase
and then stored at -20°C.
Amount

Compound

≈1.2 µg

Total RNA

2 µL

Random Decamers

to 12 µL

Nuclease Free Water

2 µL

10X RT Buffer

4µL

dNTP Mixture

1 µL

RNase Inhibitor

1µL

MMLV-RT
Total 20 µL

Table 1: Reactants for RT-PCR reactions
In order to amplify LIMK 1 and LIMK2 specific cDNA, four oligonucleotide primers were
selected. A 411 bp fragment of LIMK1 cDNA was amplified using the forward and reverse
primers 5’-TTGGACTGGCACTCTGATTGC-3’ and 5’-GGATGGCGTGATAAGAAACGGAC-3’,

respectively. A 473 bp fragment of LIMK2 cDNA was amplified using the forward and everse
primers 5’-TGGGGAAGGGTTTCTTTGGACG-3’and 5’-TAGTGTGCGTTTTTTGGTGGG-3’,
respectively. PCR was performed in the presence of dNTP as shown in Table 2. Due to
unexpected bands detected at stages 9, 11, and 20, PCR was also performed with annealing
temperatures 52°C and 50°C. The PCR products were separated in a 0.3% synergel/0.7%
agarose gel. The gel was stained using ethidium bromide and viewed with ultraviolet radiation
(Figure 2).
LIMK PCR Program
Number of Cycles

Temperature

Time

1 cycle

95°C

5 minutes

95°C

1 minute

53°C

1 minute

72°C

1 minute

1 cycle

72°C

5 minutes

unlimited

4°C

Until quit program

30 cycles

Table 2: LIMK PCR program
Trans Blotting
A 10% separating gel was prepared for the 8 cell stage, stage 6, 8, 10 , and 10.5 using
distilled water, 1.5 M TRIS HCL at pH 8.8, Acrylamide/Bis (30%), 10% SDS stock, 10% ammonium
persulfate, and TEMED. The 4% stacking gel was prepared using Distilled water, 0.5 M Tris HCl
pH 6.8, Acrylamide/Bis (30%), 10% SDS stock, 10% Ammonium persulfate, and TEMED. Embryo
equivalent amounts of protein were loaded on the gel, and the gel was run at 200 volts for
forty-five minutes. The gels were then equilibrated in transfer buffer for thirty minutes. The

Hybond membrane and saturated filter paper and fiber pads were saturated with transfer
buffer. A sandwich was assembled consisting of the gel and Hybond membrane between two
filter papers and two fiber pads was assembled and run at 197 volts for sixty minutes.
Immunoblotting
The non-specific binding sites were blocked by immersing the membrane in 5% (w/v)
blocking agent (Amersham) in PBS-T (1X PBS, 0.1% Tween 20) for one hour. The membrane was
then washed with PBS-T for fifteen minutes, followed by two further washes in PBS-T for five
minutes each. The primary antibody used recognizes active (phosphorylated) LIMK1 and LIMK2.
The primary antibody was diluted to 1:100 in PBS-T. The membrane was incubated at room
temperature in the dilute primary antibody for one hour on an orbital shaker at sixty RPM. The
membrane was washed three times with PBS-T as before, and a secondary antibody (antimouse IgG conjugated to alkaline phosphatase) was diluted 1:2000 in PBS-T. The membrane
was incubated at room temperature in the diluted secondary antibody for one hour on an
orbital shaker. The membrane was then washed three times as before with PBS-T, followed by
incubation in Enhanced chemifluorescent (ECF; Amersham) solution (an alkaline phosphatase
substrate) for approximately twenty minutes. The ECF substrate was drained off from the
membrane and the blot was placed on an absorbent surface for twenty minutes to dry. The
membrane was scanned on a Fuji FLA-3000 fluorimeter using a 570 nm filter.

Results
The Western Blot analysis (Figure 1) indicated a phosphorylated LIMK1/2 protein band
at the 8-cell stage, stage 6.5 (64 cells), 8 (early blastula), 10 (early gastrula), and 10.5 (midgastrula). A previous northern blot (Winning and Sargent 1994; Figure 2) indicated RNA bands
for EphA4 at stages 10.5, 11, 12, 15, 20 and 23.

8-cell

Stage 6.5 Stage 8

Stage 10 Stage 10.5

73 kDa

Figure 2. EphA4 northern blot of total
RNA from oocyte, unfertilized egg and
various embryonic stages, probed
with Pag cDNA (Winning and Sargent
1994).

Figure 1 Western Blot Analysis.
RNA isolated from the 8 cell
stage, stage 8, stage 10, and
stage 10.5 of embryos were
used. Samples were resolved
by SDS-PAGE, transferred to a
nitrocellulose membrane and
incubated in the p-LIMK-1/2
antibody. Sample proteins
were fluoresced using ECF
substrate and visualized using a
570 nm filter.

The expression pattern for LIMK1/2 was further analyzed using RT-PCR (Figure 3). LIMK1
and LIMK2 mRNAs were detected during stages 9, 11, and 20. Using the specific primers LIMK1
and LIMK2 produced the expected band sizes for each stage. Extra bands were also consistently
present for LIMK1 and LIMK2 at stages 9, 11, and 20 at annealing temperatures 50⁰C, 52 ⁰C, and
53 ⁰C.
LIMK 1

LIMK 2

9 11 20 9 11 20

500 bp
400 bp

Figure 3. RT-PCR Analysis.
Random primed cDNA
from stages 9, 11, and 20
were used as templates.
PCR conditions were as
follows: denaturation at
95⁰C for 60 seconds,
followed by annealing at
53⁰ C for 60 seconds, and
extension at 72⁰C for 60
seconds (for 30 cycles).

100 bp

Discussion
The Western Blot indicated that LIMK is phosphorylated and therefore active at the 8cell stage, stage 6.5, 8, 10, and 10.5 (Figure 1). Although our results indicate that LIMK is
present, we cannot differentiate between LIMK1 and LIMK2 on the western blot because the
antibody, p-LIMK-1/2 recognizes both LIMK1 and LIMK2, and the proteins co-migrate. Further
analysis of LIMK is necessary to determine which kinase is present at each stage in
development. EphA4 expression begins at stage 10.5 (Figure 2), when LIMK1/2 is also active.

These data are consistent with our hypothesis that in order for LIMK1/2 to be involved in the
EphA4 pathway, it must be expressed in development when EphA4 is expressed. This is true of
the proteins at stage 10.5; furthermore, LIMK1 and LIMK2 RNAs appear to be present at least
up to stage 20 (Figure 3). The RT-PCR analysis indicated expected bands around 411 and 473 for
LIMK1 and LIMK2, respectively. Extra bands were present, however, for LIMK1 and LIMK2 at
stages 9, 11 and 20. The extra bands are possibly the result of the primers binding to unknown
sequences in the cDNA mixture. More analyses are necessary to determine the cause of the
bands.
Future Directions
Two experiments are necessary in order to determine whether LIMK1 or LIMK2 is
inactivated in the EphA4 signaling pathway. The first would be to express a constitutively-active
LIMK1 or LIMK2 at the same time that EphA4 is active to determine whether or not LIMK
activity can rescue the embryos from the effects of EphA4. In this experiment, the introduced
LIMK activity would override the inactivation of the endogenous LIMK, preventing the effects of
EhA4 signaling. The second experiment would be to create a mutated inactive LIMK1 and LIMK2
(separately) to determine whether inactivating LIMK can produce the EphA4 phenotype.
Introducing inactive LIMK would reproduce the effects of EphA4 signaling, producing the effects
of signaling without Epha4 activity.
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